13F-HR filed by Alerce Investment Management, L.P.
Alerce Investment Management, L.P. filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 6 holding rows worth $86,935,135.
- Accession
- 0000895345-23-000105
- Filer
- CIK 1844002
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 6 entries on the cover page, a total value of $86,935,135 stated on the cover page (in dollars after the unit check, H1), rows summing to $86,935,135 with VALUE read as dollars as filed, 13F file number 028-20675. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AMERICAN WELL CORP | 03044L105 | CL A | 10,475,717 | $29,646,279 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 4,408,966 | $22,794,354 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 1,630,830 | $20,923,549 | dollars as filed | |
| AKEBIA THERAPEUTICS INC | 00972D105 | COMMON STOCK | 15,090,119 | $8,706,999 | dollars as filed | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 2,227,500 | $2,895,750 | dollars as filed | |
| REIN THERAPEUTICS INC | 00887A204 | COM NEW | 830,466 | $1,968,204 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000895345-23-000105 | this filing | 2023-02-14 | acceptance time not in the bulk data set |